Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP8062 Phase 1 SAD/MAD in Healthy Japanese Subjects
NCT03183739Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ASP8062 in alcohol use disorder (AUD) and opioid use disorder (OUD) (4 arms), sponsored by Astellas Pharma. Primary endpoints: Incidence of adverse events, Supine blood pressure and 9 more. Started Jun 2017; status: completed.
02
Drugs
ASP8062
03
Conditions
alcohol use disorder (AUD)opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03183739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03183739.